Photo: POC Manufacturing/Courtesy of Orgenesis
Orgenesis is developing a point-of-care manufacturing platform for cell and gene and other advanced therapies to make them more widely available and significantly more affordable. The platform is based on regional point-of-care (POCenters) and Orgenesis mobile production units or labs (OMPULs). These pre-fabricated units contain everything needed for manufacturing or for a lab. They are pre-validated and can be up and running quickly.
Vered Caplan, CEO of Orgenesis described the point-of-care centers as manufacturing hubs that industrialize the production of advanced therapies, such as autologous cell therapies. This is because the production can be moved from hospitals or research centers that make a few such therapies to a dedicated regional facility, thus leveraging economies of scale while still delivering fresh product to patients within a few hours after they are manufactured.
Today, many cell and gene therapies are autologous, which implies that manufacturing is personalized. A therapeutic is made patient-by-patient, which makes it so effective, but as these therapies scale, supply becomes extremely complex, Caplan told BioSpace. For example, every time you move the source material, you need special quality control testing and special logistics. Additionally, these products cannot be sterilized but must be produced in clean room conditions. For 10 patients, that isnt an issue. For 50 patients, it becomes more complicated, but now youre dealing with thousands of patients. What happens when you get to hundreds of thousands or millions of patients?
Simultaneously, on the manufacturing side, The industry is becoming much more efficient at reprogramming the cells and delivering them to their targets. But, as the process scales out, building and qualifying more and more clean rooms isnt the solution, Caplan said. Instead, We have to come up with a different system so we can quickly scale out to make these products and very quickly bring the product lines into the market.
The goal is to automate the process to remove as many manual steps as possible. You want to close the system, so its one validated package, she said. Then you can quickly duplicate it. By industrializing autologous cell and gene therapy manufacturing, it is possible to lower the cost of the therapeutic to hopefully one-fifth the current cost.
Everyone wants a fresh cellular product, so you dont want to have a manufacturing site in the middle of the country, Caplan said. You want fresh produce, close by, and a process that is automated, standardized and unitized. That way, success can be duplicated everywhere, in a very cost-effective manner.
To do that, Orgenesis is setting up supply hubs to serve medical centers in about a four-hour radius. These hubs provide everything that industrial production of cellular therapeutic processing needs. They also serve the OMPULs, which we integrate into the unitized systems in a good manufacturing practice (GMP) environment.
The POCenters are basically the size of a standard shipping container. Inside, we place OMPUL units, so theyre replaceable. We validate a unit running the required process inside, to ensure high quality, Caplan explained. We place the hardware (OMPULs) and run the software (reprogramming of the cells). We can add another OMPUL to the same POCenter to provide for another hospital or can provide a similar OMPUL to another POCenterin another region. Its like the data-centers-in-a-box concept the IT industry introduced several years ago.
The idea, she said, came from a decade of trial and error throughout the industry. Were working now on data integration, incorporating best-of-breed systems and processes to make cell therapy available for every hospital. Theres a lot of work to be done.
There are two use cases for these mobile production units or labs. Usually, its an industrial partner developing the therapeutic, but sometimes the hospitals themselves want their own supply in an OMPUL, Caplan said. Because the POCenters are only a few hours away from the patient, the cells dont have to be frozen or otherwise preserved, thus enabling optimal efficacy.
Currently, Orgenesis has about 10 POCenters in various stages of deployment. Weve been putting a lot of focus on Europe, and now were advancing more into the U.S. We just announced the latest developments at Johns Hopkins University. Were also working with the University of California - Davis and setting up in Boston and are hoping to expand to Texas, she said. The companys network of development and service centers are in place in the U.S., Europe, Israel and South Korea with research and industry partners in these locations.
The company and its collaborative partners recently received a 4 million grant to industrialize the manufacturing of induced pluripotent stem cells (iPSCs) using the OMPULs.
We want to develop a closed, automated system to make iPSCs that differentiate into any type of cell you want, and to automatically analyze those cells, Caplan shared. Today, reprogramming cells into iPSCs and then differentiating them into the desired type of cells is an extremely manual process.
In the past decade, artificial intelligence technologies have advanced amazingly in terms of their sophistication and capabilities for medical indications. AI is doing extremely well in image analysis, she pointed out, so using AI to expedite microscopical work for cell reprogramming may save a lot of time and cost, and help industrialize the process.
Original post:
- Unparalleled Research on Adipose Tissue-Derived Stem Cell Therapy Market With Current and Future Growth ... - openPR - May 15th, 2024
- 100 plus years of stem cell research20 years of ISSCR - PMC - March 26th, 2024
- Stem Cell Science and Human Research Studies Ahead of Cargo Arrival - NASA Blogs - February 18th, 2024
- Stem cell research project to launch into space - Fox Weather - January 24th, 2024
- Breakthrough in cancer research opening up stem cell therapy to more people. How you can get involved - 69News WFMZ-TV - January 20th, 2024
- Stem Cell Research Heading to the ISS on Axiom Mission 3 - ISS National Lab - January 18th, 2024
- No, Rep. Steve Scalise Didn't Vote Against Stem Cell Research From Which He Is Now Benefiting - The Dispatch - January 12th, 2024
- Applications are open for the Maryland Stem Cell Research Fund - Technical.ly - January 4th, 2024
- Global Stem Cell Therapy Market to Reach USD 928.6 Million by 2031: Says Allied Market Research - Yahoo Finance - November 19th, 2023
- Current state of stem cell-based therapies: an overview - PMC - November 3rd, 2023
- Dynamic Stem Cell Therapy Uncovers Research in Advance Regenrative Medicine - Yahoo Finance - November 3rd, 2023
- Research Fellow (Aging and Cancer Stem Cell Laboratory ... - Times Higher Education - October 15th, 2023
- Qkine Collaborates with the Cambridge Stem Cell Institute to Facilitate Same-Day Access to Key Research Products for Researchers at the Cambridge... - September 27th, 2023
- Stem cells: a comprehensive review of origins and emerging clinical ... - September 25th, 2023
- Stem Cell Research and Communicating Science | GBH - GBH News - September 20th, 2023
- Stem cell research reveals the earliest stages of a human life - SBS News - September 10th, 2023
- Stem Cell Therapy Market Size 2023 | Innovative Research Methodologies with Emerging Trends and Opportuni - Benzinga - September 10th, 2023
- Autologous Stem Cell and Non-Stem Cell Based Therapies Market Research, Current Trends, Key Industry Play - Benzinga - September 8th, 2023
- Stem Cell Therapy Market 2023 Business Statistics and Research ... - The Knox Student - August 28th, 2023
- Autologous Stem Cell Based Therapies Market Analysis, Research ... - Chatfield News-Record - July 19th, 2023
- Global Stem Cell Market Projected to Reach $14 Bn by 2028: Ken Research - Yahoo Finance - July 11th, 2023
- Theradaptive Awarded Manufacturing Assistance Grant by the Maryland Stem Cell Research Fund - Benzinga - July 10th, 2023
- Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual... - June 19th, 2023
- Sana Biotechnology Highlights Preclinical Data from Hypoimmune and Fusogen Platforms at the International Society for Stem Cell Research (ISSCR) 2023... - June 17th, 2023
- Induced Pluripotent Stem Cell (iPSC) Global Market Report 2023: Effective Research Programs Hold Key in Roll Out of Advanced iPSC Treatments - Yahoo... - June 17th, 2023
- Lung and heart stem cell research paves way for new COVID-19 treatments - Medical Xpress - June 14th, 2023
- Toxicology PhD student cultivating giant leaps in stem cell research ... - June 4th, 2023
- Harvard Stem Cell Institute (HSCI) - May 26th, 2023
- Findings may lead to improved insulin-secreting cells derived from stem ... - May 26th, 2023
- Cell Press: Stem Cell Reports - May 26th, 2023
- Stem cell research could enable blood to be made in other parts of the body - Medical Xpress - May 26th, 2023
- Construction of myocardial patch with mesenchymal stem cells and poly ... - May 22nd, 2023
- Cedars-Sinai to Send Stem Cells to the Space Station to Aid in the ... - May 22nd, 2023
- researchers expand human blood stem cells | Institute for Stem Cell ... - May 22nd, 2023
- A Look Inside Stem Cells Helps Create Personalized Regenerative ... - May 17th, 2023
- Exclusive Research Report on Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market to Witness Comp - openPR - May 17th, 2023
- The Future of Stem Cell Research: Master of Science in ... - The Daily | Case Western Reserve University - May 10th, 2023
- Exclusive Research Report on Stem Cell Therapy for Diabetes and ... - Digital Journal - May 9th, 2023
- Aging melanocyte stem cells and gray hair | National Institutes of ... - May 5th, 2023
- Mouse hair turns gray when certain stem cells get stuck - May 5th, 2023
- Science-First Skincare Company Michal Morrison Secures Exclusive World-Wide License of Proprietary STEM6 Molecule, Supported by Over 25 Years of... - May 5th, 2023
- BioCentriq and panCELLa execute research agreement to study stem cell-derived Natural Killer cell expansi - Benzinga - May 3rd, 2023
- Hair turning gray? Study finds a stem cell 'glitch' may be the cause - May 1st, 2023
- Elevai Labs Announces Research Grant Award and Partnership to Better Characterize the 'Payload' of ELEVAI's Stem Cell-derived Exosomes - Yahoo Finance - April 27th, 2023
- Why does hair turn gray? A new study says 'stuck' stem cells may ... - NPR - April 27th, 2023
- Study advances understanding of how melanocyte stem cells work to color ... - April 21st, 2023
- Stem cell research and therapy legislation to be replaced, says ... - Bahamas Tribune - April 21st, 2023
- Stem Cell Research (journal) - Wikipedia - April 21st, 2023
- Scientists Are About to Try to Create Stem Cells in Space - April 21st, 2023
- Stem Cell Research & Therapy | Articles - BioMed Central - April 16th, 2023
- Stem Cell Junk Yards Reveal a New Clue About Aging | WIRED - April 16th, 2023
- Global Stem Cells Market Research Report 2023: Implications - April 16th, 2023
- Stem cell research can help people with hard- | EurekAlert! - April 16th, 2023
- University Of Edinburgh's stem cell research gets funding boost - India Education Diary - April 14th, 2023
- Two major stem cell research projects supported with more than ... - University of California, Santa Cruz - April 8th, 2023
- Cancer detection predicts tumors before they form: discovery - March 29th, 2023
- Stem cell therapy: a potential cure for hearing loss? - March 29th, 2023
- Turkey's Only Stem Cell Production Application and Research Center - Expat Guide Turkey - March 24th, 2023
- Stem Cell Research Article, Embryonic Cells Information, Cell Therapy ... - March 24th, 2023
- Scientists create mice with cells from 2 males for 1st time - March 19th, 2023
- QBRI concludes stem cells symposium - Gulf Times - March 17th, 2023
- 2020 California Proposition 14 - Wikipedia - March 17th, 2023
- Stem Cell Reports | Journal | ScienceDirect.com by Elsevier - March 17th, 2023
- Stem cell therapy MSC-NP found to ease inflammatory activity of brain ... - March 12th, 2023
- Stem Cell Research | Office of Research Compliance | SIU - March 12th, 2023
- Heart disease study shows hope for stem cell treatment - March 4th, 2023
- Stem cells drive antler regeneration | Science - March 4th, 2023
- Stem Cell Research: Argumentative Essay - Free Essay Example - Edubirdie - March 4th, 2023
- Stem Cell Research | Thermo Fisher Scientific - US - March 4th, 2023
- Stem cell controversy - Wikipedia - February 28th, 2023
- National Institutes of Health grant funds interdisciplinary ... - February 27th, 2023
- Research Associate in Cancer Stem Cell Research job with ... - Times Higher Education - February 25th, 2023
- Pioneering Stem Cell Research Conference at The Aga Khan ... - The Aga Khan University - February 25th, 2023
- Scientists grapple with ethics of stem cell research - STAT - February 17th, 2023
- Research Associate in Stem Cell Neurobiology job with KINGS ... - Times Higher Education - January 30th, 2023
- Stem cells: past, present, and future | Stem Cell Research & Therapy ... - January 12th, 2023
- Edu Thesis & Essay: Stem cell research outline top writers online! - January 12th, 2023
- Stem Cell Biology Research Program | Johns Hopkins Institute for Cell ... - January 5th, 2023
- Stem cell population identified is vital for bone regeneration: Research - ThePrint - January 5th, 2023
- Leading scientist 'blown away' by UAE advances in stem cell research - The National - December 15th, 2022
Recent Comments